All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study

OBJECTIVES: The aim of the study was to assess all-cause mortality and cardiovascular (CV) events in patients after a period of 12 months of treatment with dual antiplatelet therapy (DAPT) after hospitalization for acute myocardial infarction (AMI) in a real-world setting. Health care costs for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Degli Esposti, Luca, Perrone, Valentina, Veronesi, Chiara, Buda, Stefano, Rossini, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251357/
https://www.ncbi.nlm.nih.gov/pubmed/30538488
http://dx.doi.org/10.2147/VHRM.S162004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251357/
https://www.ncbi.nlm.nih.gov/pubmed/30538488
http://dx.doi.org/10.2147/VHRM.S162004

Ejemplares similares